BRCA1andBRCA2germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts

High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic Lesions

(2013) A. L. Lucas et al.   CLINICAL CANCER RESEARCH

Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals

(2012) Marcia Irene Canto et al.   GASTROENTEROLOGY

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer

(2012) Marcia Irene Canto et al.   GUT

Absence of germline BRCA1 mutations in familial pancreatic cancer patients

(2010) Jennifer E. Axilbund et al.   CANCER BIOLOGY & THERAPY

Pancreatic Cancer Screening in a Prospective Cohort of High-Risk Patients: A Comprehensive Strategy of Imaging and Genetics

(2010) E. C. Verna et al.   CLINICAL CANCER RESEARCH

Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation

(2010) Hans F.A. Vasen et al.   GASTROENTEROLOGY

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

The Yield of First-Time Endoscopic Ultrasonography in Screening Individuals at a High Risk of Developing Pancreatic Cancer

(2009) J W Poley et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Head and neck squamous cell carcinoma in FAMMM syndrome

(2009) Vladimir Vinarsky et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Risk of Pancreatic Cancer in Families With Lynch Syndrome

(2009) Fay Kastrinos   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Germline BRCA1 mutations predispose to pancreatic adenocarcinoma

(2008) Wigdan Al-Sukhni et al.   HUMAN GENETICS

BRCAGermline Mutations in Jewish Patients With Pancreatic Adenocarcinoma

(2008) Cristina R. Ferrone et al.   JOURNAL OF CLINICAL ONCOLOGY